RWA Wealth Partners LLC Sells 9,950 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• RWA Wealth Partners LLC reduced its stake in Bath & Body Works by 35.8% during the first quarter, holding $542,000 worth of shares after selling nearly 10,000 shares.
• Bath & Body Works recently announced a $0.20 quarterly dividend, resulting in an annualized yield of 2.7% and a payout ratio of 21.33%.
• The company's latest earnings report showed an earnings per share of $0.49, surpassing expectations, while revenue for the quarter was $1.40 billion, slightly below forecasts.

RWA Wealth Partners LLC cut its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 35.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,875 shares of the company's stock after selling 9,950 shares during the quarter. RWA Wealth Partners LLC's holdings in Bath & Body Works were worth $542,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Golden State Wealth Management LLC raised its stake in shares of Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares in the last quarter. UMB Bank n.a. raised its stake in shares of Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares in the last quarter. Ancora Advisors LLC acquired a new position in shares of Bath & Body Works in the fourth quarter valued at $67,000. GKV Capital Management Co. Inc. acquired a new position in shares of Bath & Body Works in the first quarter valued at $69,000. Finally, Brooklyn Investment Group raised its stake in shares of Bath & Body Works by 394.9% in the first quarter. Brooklyn Investment Group now owns 2,697 shares of the company's stock valued at $82,000 after purchasing an additional 2,152 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Price Performance

Shares of NYSE:BBWI traded up $1.6350 during trading on Friday, reaching $31.0550. The stock had a trading volume of 4,792,107 shares, compared to its average volume of 4,610,963. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87. The business's 50-day moving average price is $30.30 and its 200 day moving average price is $30.97. The stock has a market capitalization of $6.57 billion, a PE ratio of 8.28, a P/E/G ratio of 1.04 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The company had revenue of $1.40 billion during the quarter, compared to analysts' expectations of $1.42 billion. During the same quarter in the previous year, the company posted $0.38 earnings per share. Bath & Body Works's quarterly revenue was up 2.9% compared to the same quarter last year. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. Analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, August 22nd. Bath & Body Works's dividend payout ratio is presently 21.33%.

Analysts Set New Price Targets

A number of brokerages recently commented on BBWI. Telsey Advisory Group restated an "outperform" rating and issued a $38.00 target price on shares of Bath & Body Works in a research note on Thursday. The Goldman Sachs Group cut their target price on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Wall Street Zen lowered Bath & Body Works from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Piper Sandler set a $39.00 target price on Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Finally, Wells Fargo & Company increased their price objective on Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 14th. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $42.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.